Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used in dogs with congestive heart failure and, in selected cases, other cardiovascular or kidney-related problems. It does not remove fluid the way furosemide does and it does not strengthen contraction the way pimobendan does. Its main role is to reduce activation of the renin-angiotensin-aldosterone system (RAAS), a hormone system that can become chronically overactive when the heart or kidneys are under stress.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion
Enalapril has a long history in canine cardiology, but its place in treatment has become more specific as evidence has evolved. It is commonly used after congestive heart failure develops as part of a multi-drug plan. It should not be assumed that every dog with a murmur or preclinical valve disease benefits from an ACE inhibitor before heart failure is present.
What ACE inhibition means
The kidneys release renin when they interpret blood flow or pressure as insufficient. Renin begins a cascade that ultimately produces angiotensin II and promotes aldosterone. Angiotensin II constricts blood vessels and helps retain sodium and water; aldosterone also encourages sodium retention and influences cardiovascular remodeling.
In the short term, that system helps preserve circulation. In chronic heart disease, persistent activation can add workload to the cardiovascular system. Enalapril inhibits angiotensin-converting enzyme, reducing production of angiotensin II and some downstream effects of RAAS activation.
Why enalapril may be used in canine heart failure
Dogs with congestive heart failure from MMVD or DCM are often treated with several medicines that address different problems. A loop diuretic such as furosemide or torsemide controls congestion. Pimobendan supports cardiac performance. Spironolactone blocks aldosterone. Enalapril provides ACE inhibition.
Merck Veterinary Manual describes ACE inhibitors as mild balanced vasodilators and neurohormonal modulators. In current canine CHF management, enalapril is often considered part of a broader “quadruple therapy” approach rather than a stand-alone treatment.
What enalapril does not do
Enalapril is not a rescue medicine for a dog struggling to breathe. It will not rapidly remove pulmonary edema. It is not a substitute for a loop diuretic, oxygen or emergency stabilization. It also is not an automatic treatment for every heart murmur.
The role of ACE inhibitors before congestive heart failure is controversial. Evidence has not shown a consistent benefit for delaying the onset of CHF in dogs with subclinical mitral regurgitation. A dog with Stage B2 MMVD may have a clear indication for pimobendan while the decision about ACE inhibition remains different.
Enalapril dosage by weight: heart-failure reference
Current Merck guidance lists enalapril at 0.25–0.5 mg/kg by mouth every 12–24 hours for canine congestive heart failure. When continuous ACE inhibition is desired and well tolerated, Merck notes that a 12-hour dosing interval is generally preferred.
| Reference context | Current canine guidance | Monitoring |
|---|---|---|
| Congestive heart failure | 0.25–0.5 mg/kg PO every 12–24 hours | Kidney function, potassium and blood pressure |
| Continuous ACE inhibition | Every-12-hour dosing may be preferred when tolerated | Clinical response and renal values guide use |
| Systemic hypertension | Similar ranges may be used | ACE inhibitors alone are usually not sufficient for severe hypertension |
Source: Merck Veterinary Manual ACE-inhibitor guidance. The dose range does not replace reassessment during dehydration, kidney disease or changes in concurrent diuretics.
Enalapril and kidney function
The kidneys use angiotensin II as part of their ability to maintain filtration pressure. Blocking that system can reduce glomerular filtration in vulnerable animals. The most important serious adverse effect of ACE inhibition is therefore a fall in kidney filtration with azotemia.
This does not mean enalapril “damages kidneys” in every dog. Many dogs tolerate it well. The risk becomes more important when a dog is dehydrated, has existing kidney disease, is taking high-dose diuretics, has low blood pressure or receives another drug that affects renal perfusion.
Why bloodwork is checked after starting
Merck recommends measuring renal values before an ACE inhibitor begins, rechecking after initiation—often within several days—and monitoring periodically thereafter. Veterinarians may assess blood urea nitrogen, creatinine, potassium and sometimes other electrolytes and blood pressure.
When a dose is increased or another diuretic is added, the monitoring clock may effectively restart. A result that was acceptable three months ago does not guarantee the same combination is still safe after a major treatment change.
Enalapril and potassium
ACE inhibitors can contribute to higher potassium concentrations because they reduce aldosterone activity. The effect may be more important when enalapril is combined with spironolactone, a potassium-sparing aldosterone antagonist, or when kidney function is reduced.
Do not give potassium supplements, electrolyte powders or potassium-containing salt substitutes unless the veterinary team specifically recommends them. Low potassium can occur in heart-failure patients taking loop diuretics, but treatment should be based on measured values, not assumptions.
Enalapril with furosemide
This is a common combination. Furosemide removes excess sodium and water, while enalapril reduces RAAS activation. The combination can improve the overall heart-failure plan, but both drugs can influence kidney perfusion when a dog is volume-depleted.
If a dog develops vomiting, diarrhea, poor appetite or reduced water intake, call the veterinary clinic. A medication plan that is appropriate when hydration is normal may need temporary reassessment during gastrointestinal illness.
Enalapril with pimobendan
Pimobendan and enalapril have different mechanisms and may be used together. Pimobendan helps cardiac performance and vasodilation; enalapril modifies RAAS. Improvement in energy or breathing after several medicines are started does not reveal which one should be stopped later.
Heart-failure drugs are usually adjusted based on disease stage, respiratory signs, blood pressure, kidney values and imaging—not because the dog looks better for a few days.
Enalapril with spironolactone
This combination is also common but deserves potassium and renal monitoring. Spironolactone blocks aldosterone at its receptor, while enalapril reduces formation of angiotensin II and thereby reduces aldosterone stimulation upstream. Both can shift potassium upward in some patients.
The presence of furosemide, which tends to promote potassium loss, can change the net effect. That is why online rules such as “ACE inhibitors always cause high potassium” or “diuretics always cause low potassium” are too simplistic for an individual dog.
NSAIDs and the kidney-risk triangle
NSAIDs can reduce prostaglandin-mediated support of kidney blood flow. An ACE inhibitor alters another component of renal autoregulation, and a diuretic reduces circulating volume. When all three factors are present—especially in a dehydrated dog—the risk of acute kidney injury can rise.
A dog with heart disease may still need pain control. Tell every veterinarian about the full cardiac medication list before an NSAID is added or restarted. Never use leftover carprofen, meloxicam, firocoxib or another NSAID without that review.
Low blood pressure
Because enalapril can lower vascular resistance, hypotension is possible, particularly when combined with other vasodilators, potent diuretics or dehydration. Marked weakness, fainting, unusual lethargy or inability to exercise can have many causes in a cardiac patient, but low blood pressure belongs on the list.
Do not try to correct suspected low blood pressure at home with salt, missed medicines or extra fluids unless the veterinary team directs you. Dogs with heart failure can be harmed by indiscriminate fluid administration.
Gastrointestinal side effects
Poor appetite, vomiting and diarrhea can occur with ACE inhibitors, although they are not the most common problem. Those signs are important because they can also dehydrate the dog and amplify renal effects from the entire heart-failure regimen.
If a dog vomits once but is otherwise well, the response may differ from repeated vomiting with weakness and poor water intake. Call the clinic when symptoms persist or when the dog takes several cardiovascular drugs.
Cough is different in dogs than in people taking ACE inhibitors
ACE inhibitors are famous for causing cough in some human patients. That adverse effect is not recognized as a common problem in dogs or cats. A coughing dog on enalapril should therefore not automatically be assumed to have an ACE-inhibitor cough.
In a dog with heart disease, cough can reflect airway disease, recurrent pulmonary edema, heart enlargement or another respiratory problem. Resting respiratory rate, examination and chest imaging may be more useful than simply stopping enalapril.
How enalapril is given
Enalapril is given orally. The prescribing veterinarian chooses dose and frequency based on the indication, dog’s size, kidney function, blood pressure and concurrent medicines. Merck notes that enalapril is converted to its active metabolite enalaprilat and is cleared mainly through the kidneys.
Because renal clearance matters, severe CHF or renal impairment can prolong exposure. This is one reason a dosing chart cannot safely replace monitoring.
Food and timing
Follow the pharmacy or veterinary label. If the dog develops nausea, ask whether giving the tablet with a small meal is appropriate. Consistency is helpful, especially when multiple heart medicines are scheduled morning and evening.
Use a medication chart when several people care for the dog. ACE inhibitors are often given once or twice daily, and accidental duplicate dosing is more likely when the household relies on memory.
What if a dose is missed?
Do not automatically give two doses together. The safest response depends on how late the dose is and how close the next scheduled dose has become. For a stable chronic patient, one missed dose may be handled differently from a dog whose overall heart-failure control is poor.
See the missed-dose guide for general principles and call the clinic if you are uncertain.
What if an extra dose is given?
ACE inhibitor overdose most often raises concern for hypotension. Kidney effects and potassium abnormalities can occur, especially with larger exposures or vulnerable patients. Contact a veterinarian or animal poison service with the drug strength, number of tablets, dog’s weight and other medications.
Merck’s toxicology guidance notes that weakness, vomiting, pale mucous membranes and heart-rate changes can occur with ACE inhibitor overdose. Do not induce vomiting or give salt unless directed by a professional.
Enalapril and pre-existing kidney disease
Renal disease does not always prohibit ACE inhibitor use. In some kidney disorders—especially protein-losing glomerular disease—RAAS blockade can be part of treatment. However, the goals, dose and monitoring may differ from heart-failure use.
A dog with both kidney disease and CHF presents a balancing problem. Too little diuresis can leave dangerous fluid in the lungs; too much volume reduction plus ACE inhibition can worsen kidney filtration. That balance is one reason follow-up laboratory testing is not optional.
Protein in the urine
ACE inhibitors have been used to reduce proteinuria in certain canine kidney diseases. A urine protein-to-creatinine ratio may be followed when that is the indication. Blood pressure and kidney values are also relevant because hypertension and proteinuria often interact.
Do not assume that a dog taking enalapril for heart failure is automatically receiving adequate treatment for protein-losing kidney disease. Those are related but distinct clinical questions.
Enalapril versus benazepril
Both are ACE inhibitors and have similar cardiovascular effects, but their elimination differs. Enalapril and its active metabolite are cleared primarily by the kidneys. Benazepril’s active metabolite is eliminated through both bile and urine in dogs. That pharmacokinetic difference may influence a veterinarian’s choice in some patients.
It does not make benazepril universally “safer for kidneys,” and it does not mean the two drugs are interchangeable tablet-for-tablet. Merck specifically notes that benazepril is not more renal-protective than other ACE inhibitors at equivalent effect.
Regulatory context in the United States
Enalapril historically had an FDA-approved veterinary product, Enacard, for canine CHF, although FDA records show that specific product approval was later withdrawn because it was no longer manufactured or marketed. Merck still identifies enalapril as the ACE inhibitor approved in the U.S. for canine CHF in its clinical discussion.
Owners may therefore receive human-labeled enalapril products or veterinary prescriptions filled through different pharmacies. What matters is that the veterinarian has prescribed the exact strength and schedule for the dog.
Dehydration, anesthesia and days when the routine changes
ACE inhibitor tolerance can change when the dog’s circulation changes. A dog that is fasting for anesthesia, losing fluid through vomiting or diarrhea, or receiving a new diuretic may be more vulnerable to low blood pressure or worsening kidney values than on an ordinary day. Veterinary teams sometimes give specific instructions about cardiovascular medicines before procedures; those instructions should be followed rather than applying a general rule from the internet.
If another clinic is performing dentistry, surgery or an emergency procedure, provide the complete medication list and the time of the last enalapril dose. The anesthetic team needs that information when planning blood-pressure support and fluids.
Older dogs and competing priorities
Many dogs taking enalapril are seniors with more than one disease. Arthritis can create pressure to use an NSAID; kidney disease can reduce tolerance for aggressive diuresis; cognitive decline can make medication schedules harder to follow. The safest plan sometimes involves compromise rather than maximizing treatment for one organ system in isolation.
Medication reconciliation at every recheck helps. Bring all bottles, supplements and over-the-counter products so that newly added medicines do not create avoidable renal or blood-pressure interactions.
Home monitoring
Enalapril does not usually create an obvious immediate effect at home. Owners should instead watch the whole heart-failure picture: resting respiratory rate, appetite, energy, fainting, vomiting, water intake and urination. Blood pressure cannot be reliably judged from behavior alone.
If the dog also receives a loop diuretic, track changes after any dose adjustment. A sharp increase in thirst and urination, reduced appetite or weakness may be more significant when ACE inhibition is present.
Questions worth asking
Ask why enalapril is being used: CHF, hypertension, proteinuria or another reason. Ask when bloodwork should be repeated, whether potassium needs monitoring, what blood-pressure goal is being used and what to do during vomiting or diarrhea.
If the dog takes an NSAID for arthritis, ask whether the combination remains appropriate. If spironolactone is added, ask when potassium and kidney values should be checked again.
Reliable references
The Merck Veterinary Manual ACE inhibitor review describes enalapril’s renal elimination, monitoring needs, interactions and clinical use. The Merck heart-failure chapter explains the current role of ACE inhibition in canine CHF.
For product history, FDA Green Book records document the withdrawal of the former Enacard veterinary product because it was no longer marketed. That is different from a safety withdrawal and should not be misread as evidence that enalapril itself became prohibited.
Bottom line
Enalapril is an established ACE inhibitor used as part of veterinary management for congestive heart failure and selected other conditions. Its key practical risks are reduced kidney filtration, hypotension and potassium changes, particularly when dehydration, potent diuretics, spironolactone or NSAIDs are also involved.
Give enalapril according to the veterinary label, keep follow-up blood tests and blood-pressure checks, report persistent vomiting or appetite loss, and make sure every clinician knows the full medication list. It is a useful drug when the indication is clear and the monitoring matches the dog’s risk.
DogMedsHub provides source-backed canine medication guidance only and does not diagnose, prescribe or replace veterinary care.
